A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051
Clinical trial NCT03301090 · COMPLETED
Trial details
- NCT number
- NCT03301090
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2019-01-19
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.